Substance use, Unlike Dolutegravir, is Associated with Mood Symptoms in People Living with HIV
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-3254
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Substance use, Unlike Dolutegravir, is Associated with Mood Symptoms in People Living with HIV ; day:27 ; month:4 ; year:2021 ; pages:1-8
Aids and behavior ; (27.4.2021), 1-8
- Creator
-
Wijer, Lisa Van de
Heijden, Wouter van der
Verseveld, Mike van
Netea, Mihai
Mast, Quirijn de
Schellekens, Arnt
Ven, André van der
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10461-021-03272-2
- URN
-
urn:nbn:de:101:1-2021061418563723414701
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wijer, Lisa Van de
- Heijden, Wouter van der
- Verseveld, Mike van
- Netea, Mihai
- Mast, Quirijn de
- Schellekens, Arnt
- Ven, André van der
- SpringerLink (Online service)
Other Objects (12)
Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi
Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir
Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir
Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda
Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment
Brief communication: efficacy and safety of the dolutegravir/lamivudine dual therapy in antiretroviral treatment-experienced Chinese people living with HIV
Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology
Living with Lavender Jane : Living with Lesbians
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study
The Living substance as such : and as organism
Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi
Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir
Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir
Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda
Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment
Brief communication: efficacy and safety of the dolutegravir/lamivudine dual therapy in antiretroviral treatment-experienced Chinese people living with HIV
Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology
Living with Lavender Jane : Living with Lesbians
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study
The Living substance as such : and as organism
Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi
Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir
Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir
Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda
Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment
Brief communication: efficacy and safety of the dolutegravir/lamivudine dual therapy in antiretroviral treatment-experienced Chinese people living with HIV
Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology
Living with Lavender Jane : Living with Lesbians
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study